Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarosh Rana

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Current Opinion in Nephrology and Hypertension|October 1, 2013
Angiogenic factors in preeclampsia: potential for diagnosis and treatmentArvind Goel, Sarosh Rana
Hypertension (Dallas, Tex. : 1979)|February 1, 2017
Angiogenic Proteins: Can These Biomarkers Help to Prevent Maternal Deaths Related to Preeclampsia?Sarosh Rana, Herriot Sannon
Hypertension (Dallas, Tex. : 1979)|April 19, 2023
Reducing the Risk of Term Preeclampsia by Risk-Stratified Timing of Birth: Time to DeliverAshish Premkumar, Sarosh Rana
Hypertension (Dallas, Tex. : 1979)|January 13, 2021
Real-World Use of Biomarkers in Management of Hypertension During Pregnancy: Adjunct to Clinical CareSunitha C Suresh, Sarosh Rana
American Journal of Obstetrics and Gynecology|August 11, 2024
Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor testingSarosh Rana, Luke P Burns
Hypertension in Pregnancy|July 29, 2014
Response to Carbillon L et al. letter titled; "The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia"Sarosh Rana, S Ananth Karumanchi
American Journal of Obstetrics and Gynecology|September 15, 2024
Real-world evidence for utility of serum angiogenic and antiangiogenic biomarker testingSarosh Rana, Luke P Burns
American Journal of Obstetrics and Gynecology|July 16, 2025
Elevating the real-world utility of sFlt-1/PlGF testing in hypertensive disorders of pregnancy: strengths and considerationsSarosh Rana, Luke P Burns
American Journal of Obstetrics and Gynecology|February 21, 2024
Clinical utility of angiogenic biomarkersEasha Patel, Sunitha Suresh, Sarosh Rana
Journal of Perinatal Medicine|April 25, 2013
The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndromeWiebke Schaarschmidt, Sarosh Rana, Holger Stepan
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Current Opinion in Nephrology and Hypertension|October 1, 2013
Angiogenic factors in preeclampsia: potential for diagnosis and treatmentArvind Goel, Sarosh Rana
Hypertension (Dallas, Tex. : 1979)|February 1, 2017
Angiogenic Proteins: Can These Biomarkers Help to Prevent Maternal Deaths Related to Preeclampsia?Sarosh Rana, Herriot Sannon
Hypertension (Dallas, Tex. : 1979)|April 19, 2023
Reducing the Risk of Term Preeclampsia by Risk-Stratified Timing of Birth: Time to DeliverAshish Premkumar, Sarosh Rana
Hypertension (Dallas, Tex. : 1979)|January 13, 2021
Real-World Use of Biomarkers in Management of Hypertension During Pregnancy: Adjunct to Clinical CareSunitha C Suresh, Sarosh Rana
American Journal of Obstetrics and Gynecology|August 11, 2024
Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor testingSarosh Rana, Luke P Burns
Hypertension in Pregnancy|July 29, 2014
Response to Carbillon L et al. letter titled; "The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia"Sarosh Rana, S Ananth Karumanchi
American Journal of Obstetrics and Gynecology|September 15, 2024
Real-world evidence for utility of serum angiogenic and antiangiogenic biomarker testingSarosh Rana, Luke P Burns
American Journal of Obstetrics and Gynecology|July 16, 2025
Elevating the real-world utility of sFlt-1/PlGF testing in hypertensive disorders of pregnancy: strengths and considerationsSarosh Rana, Luke P Burns
American Journal of Obstetrics and Gynecology|February 21, 2024
Clinical utility of angiogenic biomarkersEasha Patel, Sunitha Suresh, Sarosh Rana
Journal of Perinatal Medicine|April 25, 2013
The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndromeWiebke Schaarschmidt, Sarosh Rana, Holger Stepan
Pageof 15